Kinetik Stock Is Down 34% -- But Does a $69 Million Bet Signal a Potential Turnaround Play?

New York City-based Brave Warrior Advisors disclosed a new 1.6 million-share stake in Kinetik Holdings (NYSE: KNTK), valued at $68.8 million as of Sept. 30 and representing roughly 1.6% of its 13F-reportable AUM. Kinetik, a midstream operator focused on the Delaware Basin, is trading at $37.14 (down ~34% year-over-year) but offers an 8.5% dividend yield and reported Q3 adjusted EBITDA of $242.6 million, distributable cash flow of $158.5 million and free cash flow of $50.9 million; management cited Permian gas-market volatility and lower producer activity as near-term headwinds while continuing capacity expansion and long-duration commercial wins. The company also monetized an EPIC Crude stake for over $500 million to pay down its revolver and says full-year EBITDA guidance remains near $1 billion, suggesting Brave Warrior’s buy reflects a bet on balance-sheet repair and a rebound-and-income opportunity amid depressed share prices.

Analysis

Brave Warrior Advisors established a new 1.6 million-share stake in Kinetik Holdings (NYSE: KNTK) in Q3, a position valued at $68.8 million as of September 30 that represents roughly 1.6% of the firm's 13F-reportable AUM; this holding was not present in the prior quarter. Kinetik shares were quoted at $37.14 in the article, down about 34% year-over-year and materially underperforming the S&P 500, while the company offers an 8.5% dividend yield.

Kinetik reported Q3 adjusted EBITDA of $242.6 million, distributable cash flow of $158.5 million and free cash flow of $50.9 million despite higher capital spending tied to the Kings Landing ramp-up; TTM revenue is $1.7 billion and net income $125.5 million. Management cited Permian gas-market volatility, negative gas pricing and lower producer activity as near-term headwinds, but the company monetized an EPIC Crude stake for more than $500 million to pay down its revolver and continues to guide full-year EBITDA close to $1.0 billion.

The disclosed institutional purchase suggests a bet on balance-sheet repair, income generation and a potential operational rebound from long-duration commercial contracts and processing expansion. Key risks to that thesis are continued negative gas pricing, lower producer activity and execution/capex risk from Kings Landing; relevant forward signals to monitor include quarterly EBITDA/DCFs, gas pricing trends in the Delaware Basin and leverage metrics after revolver paydown.

Key Decisions for Investors

• Consider establishing a modest, income-oriented position sized conservatively to capture the 8.5% yield and potential upside signaled by Brave Warrior's new stake, given current share-price dislocation
• Monitor near-term indicators—Permian gas prices, producer activity, quarterly EBITDA and distributable cash flow, and post-monetization leverage—and reduce exposure if EBITDA guidance or cash-flow trends deteriorate
• Avoid large, aggressive buys until the company demonstrates sustained EBITDA and free-cash-flow recovery and successful execution of Kings Landing capex; use hedges or staggered purchases to manage commodity and execution risk